Rosetta Inpharmatics rii.com


Public lists: Pharma Startups (4732)

Rosetta Inpharmatics, a wholly owned subsidiary of Merck and Co. Inc., develops and implements technologies that will improve drug discovery.

Rosetta Inpharmatics, a wholly owned subsidiary of Merck and Co. Inc., develops and implements technologies that will improve drug discovery.

Company (Acquired)

Phone: 425-820-8900

Fax:

12040 115th Ave NE

Kirkland, 98034
Washington, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Rosetta Inpharmatics $80.2M May 12, 2001
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Rosetta Inpharmatics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors

Competitors

Company Status Description Investors

Replidyne

Louisville, Colorado, United States
IPO / Went publicReplidyne is a drug discovery and development firm focused on a new class of antibioticsLogin to see details

Xenon Pharmaceuticals

Burnaby, British Columbia, Canada
IPO / Went publicXenon Pharmaceuticals is a clinical-stage biopharmaceutical company discovering and developing a pipeline of differentiated therapeutics for orphan indications that we intend to commercialize on our own, and for larger market indications that we intend to partner with global pharmaceutical industry leaders. The company has built a core platform, Extreme Genetics, enabling the discovery of validated drug targets by studying rare human diseases with extreme traits, including diseases caused by mut...Show allLogin to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Genes associated with progression and response in chronic myeloid leukemia and uses thereof Dec 14, 2006 Sep 06, 2011 Patent
Methods to assess quality of microarrays Jun 27, 2003 Aug 04, 2009 Patent
Systems and methods for evaluating the significance of differences in biological measurements Dec 12, 2005 Jul 21, 2009 Patent
Diagnosis and prognosis of breast cancer patients Jun 14, 2002 Apr 07, 2009 Patent